Active ingredient
Flurbiprofen
1 product in the FDA listing contain Flurbiprofen, at strengths from 8.75 mg.
A non-steroidal anti-inflammatory drug. It appears once in this dataset, in a throat lozenge.
That single listing carries the FDA marketing category UNAPPROVED DRUG OTHER, meaning it is marketed without an approved application and without a monograph covering it.
Every listing
| Product | Strength | Form | Labeller | NDC |
|---|---|---|---|---|
| Rinol-STroche | 8.75 mg | Troche | Lydia Co., Ltd. | 72988-0041 |
FDA National Drug Code Directory, retrieved 4 September 2026, openFDA data last updated 2 September 2026. A listing is a registration, not an inventory: a product here may not be on a shelf, and a product on a shelf may have a lapsed listing. See methodology.
Lozenges.com is a reference publication built from FDA product listings and drug labels. It is not medical advice, diagnosis or treatment, it does not recommend any product for any condition, and it is not a substitute for a pharmacist or a doctor.